REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grants to Directors under the Instem LTIP

26 Feb 2018 07:00

RNS Number : 8537F
Instem plc
26 February 2018
 

 

Instem plc

("Instem" or the "Company")

 

Grants to Directors under the Instem Long Term Incentive Plan ('LTIP')

 

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that Chief Executive Officer, Phil Reason and Chief Financial Officer, Nigel Goldsmith have each been granted nil-cost options over 80,000 Instem ordinary shares of 10p ("Ordinary Shares") under the Company's long-term incentive plan ("LTIP").

 

These 160,000 share options will become exercisable in 2021, subject to meeting share price targets, pursuant to the rules of the LTIP, which was approved by the Board on 22 February 2018. Following exercise of the options, the resulting shares will then be subject to a minimum 12-month holding period.

 

After these grants of options, Phil Reason and Nigel Goldsmith hold a total of 384,606 and 217,500 share options, respectively whilst their holdings in Ordinary Shares remain unchanged at 665,287 and Nil, respectively.

 

 

 

For further information, please contact:

 

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO

 

Nigel Goldsmith, CFO

 

 

 

 

N+1 Singer (Nominated Adviser & Broker)

 

+44 (0) 20 7496 3000

Richard Lindley

James White

Rachel Hayes

 

 

 

 

Walbrook Financial PR

+44 (0) 20 7933 8000

Paul Cornelius

instem@walbrookpr.com

Helen Cresswell

Sam Allen

 

 

 

 

About Instem

 

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

 

Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

 

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

 

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

 

To learn more about Instem solutions and its mission, please visit instem.com.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Phil Reason

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Instem plc

b)

 

LEI

 

 

213800PILYUFNNROQX68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary Shares of 10p each

 

 

ISIN Code: GB00B3TQCK30

 

b)

 

Nature of the transaction

 

 

(i) Grant of options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s):

 

Volume(s):

(i) Nil

 

80,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

e)

 

Date of the transaction

 

 

22/02/2018

f)

 

Place of the transaction

 

 

Off market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nigel Goldsmith

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Instem plc

b)

 

LEI

 

 

213800PILYUFNNROQX68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Options over Ordinary Shares of 10p each

 

 

ISIN Code: GB00B3TQCK30

 

b)

 

Nature of the transaction

 

 

(ii) Grant of options over Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s):

 

Volume(s):

(ii) Nil

 

80,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

e)

 

Date of the transaction

 

 

22/02/2018

f)

 

Place of the transaction

 

 

Off market

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVRARWNAUUAR
Date   Source Headline
8th Sep 20232:15 pmRNSForm 8.3 - Instem plc
8th Sep 20232:00 pmRNSForm 8 (OPD) - Instem plc
8th Sep 20231:58 pmPRNForm 8.3 - Instem Plc
8th Sep 20239:50 amRNSForm 8.5 (EPT/RI)
7th Sep 20233:03 pmRNSForm 8.3 - Instem plc
7th Sep 20233:00 pmBUSForm 8.3 - INS LN
7th Sep 20231:54 pmPRNForm 8.3 - Instem Plc
7th Sep 202311:07 amRNSForm 8.3 - Instem Plc
7th Sep 202310:12 amRNSForm 8.5 (EPT/RI)
5th Sep 20236:00 pmRNSReplacement: Form 8 (OPD) - Instem plc
5th Sep 20234:15 pmRNSForm 8 (OPD) - Instem plc
5th Sep 20231:38 pmPRNForm 8.3 - Instem Plc
5th Sep 202310:48 amRNSForm 8.5 (EPT/RI)
5th Sep 20239:55 amRNSForm 8.3 - Instem Plc
4th Sep 20234:50 pmRNSForm 8.3 - Instem plc
4th Sep 20239:58 amRNSForm 8.5 (EPT/RI)
1st Sep 20233:00 pmBUSForm 8.3 - INS LN
1st Sep 20232:15 pmGNWForm 8.3 - Instem PLC
1st Sep 20231:29 pmPRNForm 8.3 - Instem Plc
1st Sep 202312:05 pmRNSForm 8.5 (EPT/RI)
1st Sep 202311:25 amRNSForm 8.3 - Instem plc
1st Sep 20237:00 amBUSForm 8.3 - Instem plc
31st Aug 20234:45 pmPRNRe-issue: Form 8.3 - Instem Plc
31st Aug 20233:00 pmBUSForm 8.3 - INS LN
31st Aug 202312:02 pmRNSForm 8.3 - Instem plc
31st Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
31st Aug 202311:44 amGNWForm 8.3 - [Instem plc - Opening Declaration - 30 08 2023] - (CGAML)
31st Aug 202311:15 amRNSForm 8.3 - Instem PLC
31st Aug 202310:29 amGNWForm 8.3 - Instem PLC
31st Aug 202310:07 amRNSForm 8.3 - Instem Plc
31st Aug 202310:02 amBUSForm 8.3 - INSTEM PLC
31st Aug 202310:01 amRNSForm 8.3 - Instem Plc
31st Aug 20239:55 amRNSForm 8.3 - Instem plc
31st Aug 20239:44 amRNSForm 8.5 (EPT/RI)
31st Aug 20239:24 amRNSHolding(s) in Company
30th Aug 202312:09 pmRNSForm 8.3 - Instem plc
30th Aug 202311:26 amRNSForm 8.3 - Instem plc
30th Aug 202310:22 amBUSForm 8.3 - INSTEM PLC
30th Aug 202310:10 amRNSForm 8.3 - Instem Plc
30th Aug 20237:00 amRNSRecommended Cash Offer
15th Aug 20237:00 amRNSTrading Update
3rd Aug 20237:30 amRNSHolding(s) in Company
31st Jul 20231:32 pmRNSHolding(s) in Company
28th Jul 202310:00 amRNSExercise of Options, Issue of Equity & TVR
27th Jul 20231:15 pmRNSHolding(s) in Company
28th Jun 20237:00 amRNSResult of AGM
2nd Jun 20238:51 amRNSNotice of AGM & Posting of Annual Report
2nd Jun 20238:38 amRNSExercise of Options, Issue of Equity & TVR
18th May 20239:14 amRNSHolding(s) in Company
15th May 20237:01 amRNSFinal Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.